Vasily Studitsky, PhD, Joins Fox Chase Cancer Center as a Professor in the Cancer Epigenetics Program
PHILADELPHIA, PA (August 9, 2013)—Vasily Studitsky, PhD, has joined Fox Chase Cancer Center as a Professor in the Cancer Epigenetics Program. He comes to Fox Chase from Wayne State University and the University of Medicine and Dentistry of New Jersey, where he was a full Professor. Dr. Studitsky’s research looks at molecular mechanisms and regulation of eukaryotic transcription, and the factors involved in cancer development and human aging.
Dr. Studitsky received his PhD from the W. Engelhardt Institute of Molecular Biology in Moscow, Russia. He did his postdoctoral fellowship at the National Institutes of Health, where he conducted research on transcription through chromatin by model bacteriophage SP6 RNA polymerase and yeast RNA polymerase III.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.